【摘要】 肝細胞癌(HCC)已占全球癌症死亡的第3位，其中半数以上病例在中国。目前我国HCC发病率仍无下降趋势，如何从源头降低HCC发病率至关重要。该文重点讨论了肝功能正常HBV携带者抗病毒治疗及他汀类药物干预非酒精性脂肪性肝病、酒精性肝病是否可以从源头降低相关HCC发病率等问题，并根据理论依据及临床观察资料提出可行性报告，旨在从源头降低HCC发病率。

    【关键词】 乙型肝炎病毒携带者;抗病毒治疗;非酒精性脂肪性肝病;酒精性肝病;肝细胞癌

    【Abstract】 Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide， and more than half of the patients are from China. At present， the incidence of HCC in China is still not declining. How to reduce the incidence of HCC from the source is of significance. In this article ......